HRSB Resources and Publications
HRSB Biennial Reports
Utilization of Breast Cancer Research and Education Funds Reports
Related Links[18]
- New York State Department of Health: Funding Opportunities[19]
- New York State Department of Environmental Conservation, Pesticide Reporting Law[20]
- Pesticide Sales and Use Reporting (PSUR) Database[21]
- New York State Grants Reform[22]
- New York State Statewide Financial System[23]
- National Institutes of Health[24]
- National Institutes of Health: Clinical Trials[25]
- PubMed[26]
External Publications
Since 1996, the HRSB’s mission has been to support innovative breast cancer scientific research and education projects within New York State. HRSB has recommended approximately $27 million in research awards through 2025 to some of New York State's finest research teams. Research listed in the table below is a result of this funding.
| Organization | Investigator(s) | Link/PubMed ID# | Publication/Abstract Title |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | Irie, Hanna | 39541980[27] | A PROTAC degrader suppresses oncogenic functions of PTK6 inducing apoptosis of breast cancer cells |
| Icahn School of Medicine at Mount Sinai | Silva, Jose | 34633138[28] | miR-424/503 modulates Wnt/β-catenin signaling in the mammary epithelium by targeting LRP6 |
| New York University | David, Gregory | bioRxiv[29] | The chromatin associated Sin3B is a critical regulator of DNA damage repair through the engagement of the Non-Homologous End Joining pathway |
| New York University | David, Gregory | bioRxiv[30] | Lipocalin 2 upregulation mediates the detrimental effects of therapy-induced senescence in breast cancer cells |
| New York University | David, Gregory | 35500379[31] | The origins of cancer cell dormancy |
| New York University | David, Gregory | 37314748[32] | Chromatin-associated SIN3B protects cancer cells from genotoxic stress-induced apoptosis and dictates DNA damage repair pathway choice |
| New York University | David, Gregory | 35953598[33] | Therapy-induced senescence promotes breast cancer cells plasticity by inducing Lipocalin-2 expression. |
| Stony Brook University | Chung, Jun | 38201253[34] | The Sensitization of Triple-Negative Breast Cancers to Poly ADP Ribose Polymerase Inhibition Independent of BRCA1/2 Mutation Status by Chemically Modified microRNA-489 |
| Stony Brook University | Chung, Jun | 37892162[35] | Combination Treatment Strategies to Overcome PARP Inhibitor Resistance |
| Stony Brook University | Chung, Jun | 39201393[36] | Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers |
| Albany Medical College | Barroso, Margarida | 39642392[37] | Modeling intratumor heterogeneity in breast cancer |